Our study also found that the C5 subgroup with high NFYB expression had the highest G2M score and a relatively higher proportion of rGBM, indicating that NFYB is highly associated with GBM proliferation and recurrence resistance, consistent with previous studies on NFYB in other cancers. The gene discussed is NFYB; the disease is cancer.